| 10 mg/ml Solution for infusion EU/1/19/1383/001-002 |
Lacosamide |
UCB Pharma S.A. |
— |
| Bimzelx 160 mg solution for injection in pre-filled pen EU/1/21/1575/005-008 |
Bimekizumab |
UCB Pharma S.A. |
— |
| Bimzelx 160 mg solution for injection in pre-filled syringe EU/1/21/1575/001-004 |
Bimekizumab |
UCB Pharma S.A. |
— |
| Bimzelx 320 mg solution for injection in pre-filled pen EU/1/21/1575/011-012 |
Bimekizumab |
UCB Biopharma SPRL |
— |
| Bimzelx 320 mg solution for injection in pre-filled syringe EU/1/21/1575/009-010 |
Bimekizumab |
UCB Biopharma SPRL |
— |
| Briviact 10 mg film-coated tablets EU/1/15/1073/001-004 |
Brivaracetam |
UCB Pharma S.A. |
— |
| Briviact 10 mg/ml oral solution EU/1/15/1073/021 |
Brivaracetam |
UCB Pharma S.A. |
— |
| Briviact 10 mg/ml solution for injection/infusion EU/1/15/1073/022 |
Brivaracetam |
UCB Pharma S.A. |
— |
| Briviact 100 mg film-coated tablets EU/1/15/1073/017-020 |
Brivaracetam |
UCB Pharma S.A. |
— |
| Briviact 25 mg film-coated tablets EU/1/15/1073/005-008 |
Brivaracetam |
UCB Pharma S.A. |
— |
| Briviact 50 mg film-coated tablets EU/1/15/1073/009-012 |
Brivaracetam |
UCB Pharma S.A. |
— |
| Briviact 75 mg film-coated tablets EU/1/15/1073/013-016 |
Brivaracetam |
UCB Pharma S.A. |
— |
| Cimzia 200 mg solution for injection in pre-filled syringe EU/1/09/544/1-2 |
Certolizumab pegol |
UCB Pharma S.A. |
— |
| EVENITY 105 mg solution for injection in pre-filled pen EU/1/19/1411/001-002 |
ROMOSOZUMAB |
UCB Pharma S.A. |
— |
| EVENITY 105 mg solution for injection in pre-filled syringe EU/1/19/1411/003-004 |
ROMOSOZUMAB |
UCB Pharma S.A. |
— |
| Fintepla 2.2 mg/ml oral solution EU/1/20/1491/001-004 |
Fenfluramine hydrochloride |
UCB Pharma S.A. |
— |
| Keppra 100 mg/ml concentrate for solution for infusion EU/1/00/146/033 |
Levetiracetam |
UCB Pharma S.A. |
— |
| Keppra 100 mg/ml oral solution EU/1/00/146/027 |
Levetiracetam |
UCB Pharma S.A. |
— |
| Keppra 1000 mg film-coated tablets EU/1/00/146/020-026 |
Levetiracetam |
UCB Pharma S.A. |
— |
| Keppra 250 mg film-coated tablets EU/1/00/146/001-005 |
Levetiracetam |
UCB Pharma S.A. |
— |
| Keppra 500 mg film-coated tablets EU/1/00/146/006-013 |
Levetiracetam |
UCB Pharma S.A. |
— |
| Keppra 750 mg film-coated tablets EU/1/00/146/014-019 |
Levetiracetam |
UCB Pharma S.A. |
— |
| Lacosamide UCB 10 mg/ml Syrup EU/1/19/1383/003 |
Lacosamide |
UCB Pharma S.A. |
— |
| Lacosamide UCB 100 mg Film-coated tablet EU/1/19/1383/010-015 |
Lacosamide |
UCB Pharma S.A. |
— |
| Lacosamide UCB 150 mg Film-coated tablet EU/1/19/1383/016-021 |
Lacosamide |
UCB Pharma S.A. |
— |
| Lacosamide UCB 200 mg Film-coated tablet EU/1/19/1383/022-027 |
Lacosamide |
UCB Pharma S.A. |
— |
| Lacosamide UCB 50 mg Film-coated tablet EU/1/19/1383/004-009 |
Lacosamide |
UCB Pharma S.A. |
— |
| Neupro EU/1/05/331/1-3,14-20 |
Rotigotine |
UCB Pharma S.A. |
— |
| Neupro EU/1/05/331/38-46 |
Rotigotine |
UCB Pharma S.A. |
— |
| Neupro EU/1/05/331/47-55 |
Rotigotine |
UCB Pharma S.A. |
— |
| Rystiggo 140 mg/ml solution for injection EU/1/23/1780/001 |
Rozanolixizumab |
UCB Pharma S.A. |
— |
| Tylex 30 mg/500 mg Hard Capsules PA0891/014/001 |
Codeine phosphate hemihydrate, Paracetamol |
UCB (Pharma) Ireland Limited, |
Marketed |
| Vimpat 10 mg/ml solution for infusion EU/1/08/470/16 |
Lacosamide |
UCB Pharma S.A. |
— |
| Vimpat 10 mg/ml syrup EU/1/08/470/018-019 |
Lacosamide |
UCB Pharma S.A. |
— |
| Vimpat 100 mg film-coated tablets EU/1/08/470/4-6 |
Lacosamide |
UCB Pharma S.A. |
— |
| Vimpat 15 mg/ml syrup EU/1/08/470/14-15 |
Lacosamide |
UCB Pharma S.A. |
— |
| Vimpat 150 mg film-coated tablets EU/1/08/470/7-9 |
Lacosamide |
UCB Pharma S.A. |
— |
| Vimpat 200 mg film-coated tablets EU/1/08/470/10-12 |
Lacosamide |
UCB Pharma S.A. |
— |
| Vimpat 50 mg film-coated tablets EU/1/08/470/1-3 |
Lacosamide |
UCB Pharma S.A. |
— |
| Vimpat 50mg/ 100mg/ 150mg film-coated tablets EU/1/08/470/13 |
Lacosamide |
UCB Pharma S.A. |
— |
| Xyrem 500 mg/mL oral solution EU/1/05/312/001 |
Sodium Oxybate |
UCB Pharma S.A. |
— |
| Xyzal 0.5 mg/ml oral solution PA0891/003/003 |
Levocetirizine dihydrochloride |
UCB (Pharma) Ireland Limited, |
Marketed |
| Xyzal 5 mg film-coated tablets PA0891/003/001 |
Levocetirizine dihydrochloride |
UCB (Pharma) Ireland Limited, |
Marketed |
| Xyzal 5 mg/ml oral drops, solution PA0891/003/002 |
Levocetirizine dihydrochloride |
UCB (Pharma) Ireland Limited, |
Not marketed |
| Zilbrysq 16.6 mg solution for injection in pre-filled syringe EU/1/23/1764/001-002 |
Zilucoplan |
UCB Pharma S.A. |
— |
| Zilbrysq 23 mg solution for injection in pre-filled syringe EU/1/23/1764/003-004 |
Zilucoplan |
UCB Pharma S.A. |
— |
| Zilbrysq 32.4 mg solution for injection in pre-filled syringe EU/1/23/1764/005-006 |
Zilucoplan |
UCB Pharma S.A. |
— |
| Zirtek 1 mg/ml oral solution PA0891/008/003 |
Cetirizine dihydrochloride |
UCB (Pharma) Ireland Limited, |
Marketed |
| Zirtek 10 mg film-coated tablets PA0891/008/002 |
Cetirizine hydrochloride |
UCB (Pharma) Ireland Limited, |
Marketed |
| Zirtek 10 mg/ml Oral Drops, Solution PA0891/008/004 |
Cetirizine dihydrochloride |
UCB (Pharma) Ireland Limited, |
Not marketed |